Review: Genetic diversity of Plasmodium falciparum: asexual stages

keywords malaria, Plasmodium falciparum, polymorphism, drug resistancecorrespondence Christian G. Meyer, Bernhard-Nocht-Institut fu¨r Tropenmedizin, Bernhard-Nocht-Str. 74, 20359 Hamburg, Germany. Fax: +49 40 4281 8512; E-mail: c.g.meyer@bni.uni-hamburg.deIntroductionThe genetic complexity of Plasmodium falciparum, theinfectious agent of malignant malaria, and in particular itsability to generate mutant variants, make it a successfulpathogen. Genetic variants are involved in pathogenicityand in immune responses and have led to the emergence ofresistance against virtually any drug available for causativetreatment. Such variants areunder strongselective pressure.Analysesofsequencevariationingenesegmentsthatarenotsubjectedtoselectionandofintergenicsequencespermitthestudy of additional mutation patterns, interpopulationdiversity of the parasite and its evolutionary origin.The genomeThe genome of P. falciparum consists of 14 linearchromosomes with a total of 25–30 megabases of nuclearDNA with approximately 5000 genes, a mitochondrialfragment of a 6 kb repeat element, and a circular elementof 35 kb within the apicoplast. As a consequence ofcontinuous deletions and crossing-over and rearrangementevents occurring preferably at their telomeric regions, thechromosomes differ considerably in size (Corcoran et al.1986). The genome is extremely A/T-rich (80%), whichhas led to difficulties in conventional sequencing strategiesbecause of the instability of genomic fragments in bacterialEscherichia coli clones. Meanwhile, several yeast artificialclone (YAC) constructs have been established, allowing fora stable maintenance of P. falciparum clone fragments.Essentially based on YAC contiguous sequences (con-tigs), the P. falciparum genome is now subject of a largeDNA-sequencing project, the Malaria Genome Project,which was established in 1996. Contig arrays andrestriction maps have been produced for mapping ofcomplete chromosomes (Rubio et al. 1995). At present, themajority of the sequences of the 14 chromosomes of theP. falciparum clone 3D7 are covered by YAC contigs.Sequencing is performed by a chromosomal shotguntechnique with a 10–15· coverage. The project is fundedby the Wellcome Trust, the Burroughs Wellcome Fund, theUS Department of Defence, and the National Institute ofAllergy and Infectious Diseases (US) and performed byStandford University (US), the Sanger Centre (UK), theInstitute for Genomic Research (TIGR, US), and contri-buting groups. Sequencing is close to completion andsequences are published for chromosome 2 and 3 (Gardneret al. 1998; Bowman et al. 1999; sequence of chromosome5 not yet published). Gaps still remain to be filled in otherchromosomes. The closure of gaps is complicated by theconsiderable number of A/T-repeats. Sequencing of thecytoplasmatic mitochondrial and apicoplast segments hasbeen completed. A draft sequence of the P. falciparum 3D7genome is expected to be published this year.Sequence information is being deposited in severalclickable databases (Table 1). The information available atpresent has, by in silico analysis of genetic similarity withother organisms, allowed to trace and to assign a functionto approximately 40% of the genes. Many of them encodeproteins of metabolic pathways. The sequence informationfinally provided will, after the determination of transcrip-tion patterns and the identification of coding sequences,support detailed analyses of relevant proteins, parasite-specific metabolic pathways and, furthermore, support theidentification of targets for new drugs and for vaccines.Targets for drugs are now continuously being identified.One example described on the basis of P. falciparum DNAsequence information are nuclear genes that are involved inthe pathway of lipid synthesis and the subsequentidentification of the enoyl acyl-carrier protein (Waller et al.

[1]  P. Kremsner,et al.  High Prevalence of Human Antibodies to Recombinant Duffy Binding-Like α Domains of the Plasmodium falciparum-Infected Erythrocyte Membrane Protein 1 in Semi-Immune Adults Compared to That in Nonimmune Children , 2001, Infection and Immunity.

[2]  D. Conway,et al.  Comparative analysis of Plasmodium reichenowi and P. falciparum erythrocyte-binding proteins reveals selection to maintain polymorphism in the erythrocyte-binding region of EBA-175. , 2001, Molecular and biochemical parasitology.

[3]  J. Carlton,et al.  Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum. , 2001, Current opinion in microbiology.

[4]  D. Hartl,et al.  Recent Origin of Plasmodium falciparum from a Single Progenitor , 2001, Science.

[5]  D. Conway,et al.  Extreme geographical fixation of variation in the Plasmodium falciparum gamete surface protein gene Pfs48/45 compared with microsatellite loci. , 2001, Molecular and biochemical parasitology.

[6]  P. Ringwald,et al.  Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaoundé, Cameroon. , 2001, The Journal of infectious diseases.

[7]  L. Ranford-Cartwright,et al.  Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine. , 2001, Experimental parasitology.

[8]  P. Nasveld,et al.  Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. , 2001, The Journal of infectious diseases.

[9]  H. Babiker,et al.  High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. , 2001, The Journal of infectious diseases.

[10]  R. Anders,et al.  Specificity of the Protective Antibody Response to Apical Membrane Antigen 1 , 2001, Infection and Immunity.

[11]  M. Dgedge,et al.  Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. , 2001, The Journal of infectious diseases.

[12]  Ashutosh Kumar Singh,et al.  Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. , 2001, The Journal of infectious diseases.

[13]  P. Rosenthal,et al.  Comparison of Efficacies of Cysteine Protease Inhibitors against Five Strains of Plasmodium falciparum , 2001, Antimicrobial Agents and Chemotherapy.

[14]  J. M. Rubio,et al.  Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  K. Kain,et al.  Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. , 2001, The Journal of infectious diseases.

[16]  N. Surolia,et al.  Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum , 2001, Nature Medicine.

[17]  D. Warhurst A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[18]  D. Holt,et al.  The sequence of clag 9, a subtelomeric gene of plasmodium falciparum is highly conserved. , 2000, Molecular and biochemical parasitology.

[19]  Thomas E. Wellems,et al.  Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P. falciparum , 2000, Nature.

[20]  J. Wootton,et al.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.

[21]  S. Kyes,et al.  Var gene diversity in Plasmodium falciparum is generated by frequent recombination events. , 2000, Molecular and biochemical parasitology.

[22]  H. Ginsburg,et al.  Antimalarial drug development and new targets. , 2000, Parasitology today.

[23]  J. T. Williams,et al.  Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. , 2000, Molecular biology and evolution.

[24]  X. Su,et al.  Complex mutations in a high proportion of microsatellite loci from the protozoan parasite Plasmodium falciparum , 2000, Molecular ecology.

[25]  Q. Cheng,et al.  Mutations in Plasmodium falciparumCytochrome b That Are Associated with Atovaquone Resistance Are Located at a Putative Drug-Binding Site , 2000, Antimicrobial Agents and Chemotherapy.

[26]  I. Charles,et al.  Survey of the allelic frequency of a NOS2A promoter microsatellite in human populations: assessment of the NOS2A gene and predisposition to infectious disease. , 2000, Nitric oxide : biology and chemistry.

[27]  A. Vogler,et al.  Polymorphic microsatellite markers identified in individual Plasmodium falciparum oocysts from wild-caught Anopheles mosquitoes , 2000, Parasitology.

[28]  X. Su,et al.  Microsatellite markers and genetic mapping in Plasmodium falciparum. , 2000, Parasitology today.

[29]  N. Gogtay,et al.  Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India , 2000, Annals of tropical medicine and parasitology.

[30]  J. May,et al.  Impact of subpatent multi-species and multi-clonal plasmodial infections on anaemia in children from Nigeria. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  F. Ayala,et al.  Population structure and recent evolution of Plasmodium falciparum. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Conway,et al.  A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses , 2000, Nature Medicine.

[33]  G. Dorsey,et al.  Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. , 2000, The American journal of tropical medicine and hygiene.

[34]  N. Gogtay,et al.  A randomized, parallel-group study in Mumbai (Bombay), comparing chloroquine with chloroquine plus sulfadoxine-pyrimethamine in the treatment of adults with acute, uncomplicated, Plasmodium falciparum malaria. , 2000, Annals of tropical medicine and parasitology.

[35]  M. Duraisingh,et al.  Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum , 2000, Molecular microbiology.

[36]  M. Duraisingh,et al.  The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. , 2000, Molecular and biochemical parasitology.

[37]  R. Schirmer,et al.  Deletion of the parasite-specific insertions and mutation of the catalytic triad in glutathione reductase from chloroquine-sensitive Plasmodium falciparum 3D7. , 2000, Molecular and biochemical parasitology.

[38]  I. Adagu,et al.  Correlation of in vivo‐resistance to chloroquine and allelic polymorphisms in Plasmodium falciparum isolates from Uganda , 2000, Tropical medicine & international health : TM & IH.

[39]  K. Kirk,et al.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.

[40]  B. Sharp,et al.  Chloroquine-resistant isolates of Plasmodium falciparum with alternative CG2 omega repeat length polymorphisms. , 2000, The American journal of tropical medicine and hygiene.

[41]  J. Lambert,et al.  Economic impact of febrile morbidity and use of permethrin-impregnated bed nets in a malarious area II. Determinants of febrile episodes and the cost of their treatment and malaria prevention. , 2000, The American journal of tropical medicine and hygiene.

[42]  N. Anstey,et al.  Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. , 1999, The Journal of infectious diseases.

[43]  M. Wahlgren,et al.  Small, Clonally Variant Antigens Expressed on the Surface of the Plasmodium falciparum–Infected Erythrocyte Are Encoded by the rif Gene Family and Are the Target of Human Immune Responses , 1999, The Journal of experimental medicine.

[44]  J C Wootton,et al.  A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. , 1999, Science.

[45]  C. Chitnis,et al.  Plasmodium falciparum Field Isolates Commonly Use Erythrocyte Invasion Pathways That Are Independent of Sialic Acid Residues of Glycophorin A , 1999, Infection and Immunity.

[46]  C. Plowe,et al.  Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela. , 1999, The American journal of tropical medicine and hygiene.

[47]  V. Nussenzweig,et al.  Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials. , 1999, Parassitologia.

[48]  F. von Sonnenburg,et al.  Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes. , 1999, The American journal of tropical medicine and hygiene.

[49]  R. Gwilliam,et al.  The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum , 1999, Nature.

[50]  S. Kyes,et al.  Rifins: a second family of clonally variant proteins expressed on the surface of red cells infected with Plasmodium falciparum. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  X. Su,et al.  Twelve microsatellite markers for characterization of Plasmodium falciparum from finger-prick blood samples , 1999, Parasitology.

[52]  I. Adagu,et al.  Allele-specific, nested, one tube PCR: application to Pfmdr1 polymorphisms in Plasmodium falciparum , 1999, Parasitology.

[53]  R. Price,et al.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.

[54]  J. E. Hyde,et al.  Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy , 1999, Molecular microbiology.

[55]  B. Lell,et al.  HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families. , 1999, The Journal of infectious diseases.

[56]  V. C. Pandey,et al.  Glutathione‐S‐transferase activity in malarial parasites , 1999, Tropical medicine & international health : TM & IH.

[57]  S. Looareesuwan,et al.  Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. , 1999, The American journal of tropical medicine and hygiene.

[58]  H. Ginsburg,et al.  Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. , 1998, Biochemical pharmacology.

[59]  E V Koonin,et al.  Chromosome 2 sequence of the human malaria parasite Plasmodium falciparum. , 1998, Science.

[60]  D. Roos,et al.  Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Ringwald,et al.  Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum. , 1998, The American journal of tropical medicine and hygiene.

[62]  X. Su,et al.  Plasmodium falciparum: parasite typing by using a multicopy microsatellite marker, PfRRM. , 1998, Experimental parasitology.

[63]  F. Ayala,et al.  Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. , 1998, Genetics.

[64]  C. Wongsrichanalai,et al.  High prevalence of Plasmodium malariae and Plasmodium ovale in malaria patients along the Thai‐Myanmar border, as revealed by acridine orange staining and PCR‐based diagnoses , 1998, Tropical medicine & international health : TM & IH.

[65]  G. Butcher Cross-species Immunity in Malaria. , 1998, Parasitology today.

[66]  Kevin Marsh,et al.  Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria , 1998, Nature Medicine.

[67]  Warhurst Dc,et al.  Plasmodium falciparum : in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon , 1998 .

[68]  I. Adagu,et al.  Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1Asn86Tyr polymorphism in Lambarene, Gabon , 1998, Parasitology.

[69]  O. Doumbo,et al.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. , 1997, The Journal of infectious diseases.

[70]  B. Pradines,et al.  Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing. , 1997, The American journal of tropical medicine and hygiene.

[71]  X. Su,et al.  Complex Polymorphisms in an ∼330 kDa Protein Are Linked to Chloroquine-Resistant P. falciparum in Southeast Asia and Africa , 1997, Cell.

[72]  F. Ayala,et al.  Plasmodium falciparum antigenic diversity: evidence of clonal population structure. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  R. Price,et al.  Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[74]  T. Wellems,et al.  Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. , 1997, Microbiology and molecular biology reviews : MMBR.

[75]  H. Lipps,et al.  Limited sequence polymorphism in the Plasmodium falciparum merozoite surface protein 3. , 1997, Molecular and biochemical parasitology.

[76]  T. Wellems,et al.  Antifolate drug resistance and point mutations in Plasmodium falciparum in Kenya. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[77]  X. Su,et al.  Plasmodium falciparum: a rapid DNA fingerprinting method using microsatellite sequences within var clusters. , 1997, Experimental parasitology.

[78]  T. Taraschi,et al.  Plasmodium falciparum: a simple, rapid method for detecting parasite clones in microtiter plates. , 1997, Experimental parasitology.

[79]  N. White,et al.  The epidemiology of severe malaria in an area of low transmission in Thailand. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[80]  Y. D. Sharma,et al.  Variations in the C-terminal repeats of the knob-associated histidine-rich protein of Plasmodium falciparum. , 1997, Biochimica et biophysica acta.

[81]  J. E. Hyde,et al.  Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization , 1997, Molecular microbiology.

[82]  C. Newbold,et al.  The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[83]  O. Sköld,et al.  Plasmodium falciparum: mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient. , 1996, Experimental parasitology.

[84]  R. Schirmer,et al.  Molecular cloning and characterization of a putative glutathione reductase gene, the PfGR2 gene, from Plasmodium falciparum. , 1996, European journal of biochemistry.

[85]  A. Cowman,et al.  Plasmodium falciparum: amplification and overexpression of pfmdr1 is not necessary for increased mefloquine resistance. , 1996, Experimental parasitology.

[86]  X. Su,et al.  Plasmodium falciparum: isolation of large numbers of parasite clones from infected blood samples. , 1996, Experimental parasitology.

[87]  X. Su,et al.  Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. , 1996, Genomics.

[88]  R. Coppel,et al.  Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum. , 1996, Molecular and biochemical parasitology.

[89]  T. Theander,et al.  Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan. , 1996, The American journal of tropical medicine and hygiene.

[90]  Y. D. Sharma,et al.  Allelic forms of the knob associated histidine‐rich protein gene of Plasmodium falciparum , 1996, FEBS letters.

[91]  T. Wellems,et al.  Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[92]  H. Ginsburg,et al.  Heme Degradation in the Presence of Glutathione , 1995, The Journal of Biological Chemistry.

[93]  J. Cox-Singh,et al.  Assessment of the association between three pfmdr1 point mutations and chloroquine resistance in vitro of Malaysian Plasmodium falciparum isolates. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[94]  Theodore F. Taraschi,et al.  Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes , 1995, Cell.

[95]  Joseph D. Smith,et al.  Switches in expression of plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes , 1995, Cell.

[96]  X. Su,et al.  The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes , 1995, Cell.

[97]  O. Doumbo,et al.  Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. , 1995, The American journal of tropical medicine and hygiene.

[98]  J. Le bras,et al.  Plasmodium falciparum: detection of antifolate resistance by mutation-specific restriction enzyme digestion. , 1995, Experimental parasitology.

[99]  J. E. Hyde,et al.  A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. , 1995, Molecular and biochemical parasitology.

[100]  T. Triglia,et al.  A YAC contig map of Plasmodium falciparum chromosome 4: characterization of a DNA amplification between two recently separated isolates. , 1995, Genomics.

[101]  M. Alpers,et al.  Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea. , 1994, Experimental parasitology.

[102]  J. E. Hyde,et al.  Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. , 1994, European journal of biochemistry.

[103]  G. Snounou,et al.  Mixed Infections with Plasmodium falciparum and P malariae and fever In malaria , 1994, The Lancet.

[104]  A. Cowman,et al.  Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[105]  G. Snounou,et al.  The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[106]  R. Bayoumi,et al.  Digital codes from hypervariable tandemly repeated DNA sequences in the Plasmodium falciparum circumsporozoite gene can genetically barcode isolates. , 1993, Molecular and biochemical parasitology.

[107]  W. Jarra,et al.  Assessment of parasite population dynamics in mixed infections of rodent plasmodia , 1992, Parasitology.

[108]  H. Webster,et al.  Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[109]  A. Cowman,et al.  Selection for high‐level chloroquine resistance results in deamplification of the pfmdr1 gene and increased sensitivity to mefloquine in Plasmodium falciparum. , 1992, The EMBO journal.

[110]  Kevin Marsh,et al.  Rapid switching to multiple antigenic and adhesive phenotypes in malaria , 1992, Nature.

[111]  D. Kemp Antigenic diversity and variation in blood stages of Plasmodium falciparum , 1992, Immunology and cell biology.

[112]  T. Wellems,et al.  An RFLP map of the Plasmodium falciparum genome, recombination rates and favored linkage groups in a genetic cross. , 1992, Molecular and biochemical parasitology.

[113]  M. Fry,et al.  Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). , 1992, Biochemical pharmacology.

[114]  I. Gluzman,et al.  Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. , 1992, Biochemical pharmacology.

[115]  J. Meis,et al.  Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle. , 1991, Molecular and biochemical parasitology.

[116]  T. Wellems,et al.  Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon. , 1991, The American journal of tropical medicine and hygiene.

[117]  T. Wellems,et al.  Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[118]  B. Fenton,et al.  Structural and antigenic polymorphism of the 35- to 48-kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum , 1991, Molecular and cellular biology.

[119]  A. Cowman,et al.  Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum , 1990, Nature.

[120]  Thomas E. Wellems,et al.  Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross , 1990, Nature.

[121]  B. Fenton,et al.  Genetic diversity of Plasmodium falciparum shows geographical variation. , 1990, The American journal of tropical medicine and hygiene.

[122]  W. Milhous,et al.  Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[123]  A. Cowman,et al.  Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum , 1989, Cell.

[124]  C. Wilson,et al.  Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. , 1989, Science.

[125]  A. Cowman,et al.  Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[126]  T. Richie Interactions between malaria parasites infecting the same vertebrate host , 1988, Parasitology.

[127]  T. Burkot,et al.  Measurement of malarial infectivity of human populations to mosquitoes in the Madang area, Papua New Guinea , 1988, Parasitology.

[128]  T. Horii,et al.  Pyrimethamine resistant Plasmodium falciparum: overproduction of dihydrofolate reductase by a gene duplication. , 1987, Molecular and biochemical parasitology.

[129]  D Payne,et al.  Spread of chloroquine resistance in Plasmodium falciparum. , 1987, Parasitology today.

[130]  T. Burkot,et al.  Genetic analysis of the human malaria parasite Plasmodium falciparum. , 1987, Science.

[131]  K. Tanabe,et al.  Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. , 1987, Journal of molecular biology.

[132]  W. Milhous,et al.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. , 1987, Science.

[133]  L. Corcoran,et al.  Chromosome size polymorphisms in plasmodium falciparum can involve deletions and are frequent in natural parasite populations , 1986, Cell.

[134]  P Manson,et al.  Tropical Medicine and Hygiene , 1914, British medical journal.

[135]  A. Kaneko Malaria on Islands , 2003 .

[136]  S. Kyes,et al.  Antigenic variation at the infected red cell surface in malaria. , 2001, Annual review of microbiology.

[137]  C. Canfield,et al.  MALARONE (cid:121) (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE): A REVIEW OF ITS CLINICAL DEVELOPMENT FOR TREATMENT OF MALARIA , 1999 .

[138]  X. Su,et al.  Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. , 1997, Cell.

[139]  M. Miles,et al.  Rapid detection of pfmdr1 mutations in chloroquine-resistant Plasmodium falciparum malaria by polymerase chain reaction analysis of blood spots. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[140]  E. Kimura,et al.  Genetic diversity in the major merozoite surface antigen of Plasmodium falciparum: high prevalence of a third polymorphic form detected in strains derived from malaria patients. , 1990, Gene.

[141]  ScienceDirect Molecular and biochemical parasitology , 1980 .

[142]  R. Carter,et al.  Enzyme variation in Plasmodium falciparum in the Gambia. , 1973, Transactions of the Royal Society of Tropical Medicine and Hygiene.